Erythromycin Ophthalmic Ointment Shortage

• • Akorn has ceased operation in February 2023.
  • Armas has erythromycin ophthalmic ointment available via wholesalers and direct orders.
  • Bausch Health has erythromycin ophthalmic ointment available.
  • Padagis discontinued erythromycin ophthalmic ointment in August 2023.

• • Erythromycin ophthalmic ointment, Armas Pharmaceuticals, 0.5%, 1 gram tube, 50 count, NDC 72485-0670-31
  • Erythromycin ophthalmic ointment, Armas Pharmaceuticals, 0.5%, 3.5 gram tube, 1 count, NDC 72485-0670-35
  • Erythromycin ophthalmic ointment, Bausch Health, 0.5%, 1 gram tube, 50 count, NDC 24208-0910-19
  • Erythromycin ophthalmic ointment, Bausch Health, 0.5%, 3.5 gram tube, 1 count, NDC 24208-0910-55

Estimated Resupply Dates

• • All marketed presentations are available.

Alternative Agents & Management

• • CDC recommends ceftriaxone given intravenously or intramuscularly as an alternative during this shortage. More details can be found at: https://www.cdc.gov/std/treatment/drug-notices.htm